{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:39:46Z","timestamp":1789468786196,"version":"build-2803163510"},"reference-count":28,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder caused by various underlying diseases or conditions and should be distinguished from the inherited type of von Willebrand disease. AVWS is associated with underlying diseases such as cardiovascular, autoimmune, malignant, proliferative disorders, or with mechanical circulatory support (MCS). AVWS was first reported in 1968 and most case reports describe AVWS in adults. However, AVWS can appear in pediatric patients occasionally as well. Because bleeding complications are rare in everyday life, AVWS may be underdiagnosed in pediatric patients. Therefore, the diagnosis should be suspected in a pediatric patient who is known for one of these underlying diseases or conditions and who presents with an onset of bleeding symptoms, especially before the child will undergo an invasive procedure. Here, we present an overview of the diagnostic analyses regarding AVWS and of the underlying diseases or conditions in which AVWS should be considered. Importantly, the patient's history should be investigated for bleeding symptoms (mucocutaneous or postoperative bleeding). As no single routine coagulation test can reliably confirm or exclude AVWS, the diagnosis may be challenging. Laboratory investigations should include analysis of von Willebrand factor (VWF):antigen, VWF:collagen-binding capacity, VWF:activity, and VWF multimeric analyses. For treatment, tranexamic acid, 1-desamino-8-D-arginine vasopressin, and VWF-containing concentrate can be used. AVWS disappears after the underlying disease has been successfully treated or the MCS has been explanted.<\/jats:p>","DOI":"10.1055\/a-1790-6156","type":"journal-article","created":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T03:06:59Z","timestamp":1651288019000},"page":"117-122","source":"Crossref","is-referenced-by-count":8,"title":["Acquired von Willebrand Syndrome in Children"],"prefix":"10.1055","volume":"42","author":[{"given":"Kirstin","family":"Sandrock-Lang","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center \u2013 University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Glonnegger","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center \u2013 University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Zieger","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center \u2013 University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"issue":"S 01","key":"ref1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1538-7836.2011.04324.x","article-title":"von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein","volume":"9","author":"R Schneppenheim","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejcts.2007.12.047","article-title":"Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease","volume":"33","author":"U Geisen","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.thromres.2014.04.033","article-title":"Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo","volume":"134","author":"U Geisen","year":"2014","journal-title":"Thromb Res"},{"issue":"25","key":"ref4","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","article-title":"How I treat the acquired von Willebrand syndrome","volume":"117","author":"A Tiede","year":"2011","journal-title":"Blood"},{"issue":"06","key":"ref5","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.transci.2018.10.012","article-title":"Management of acquired von Willebrand syndrome","volume":"57","author":"J Charlebois","year":"2018","journal-title":"Transfus Apheresis Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"625632","DOI":"10.3389\/fped.2021.625632","article-title":"Hemostatic challenges in pediatric critical care medicine-hemostatic balance in VAD","volume":"9","author":"M B Ghbeis","year":"2021","journal-title":"Front Pediatr"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/icvts\/ivu305","article-title":"Shear-stress induced acquired von Willebrand syndrome in children with congenital heart disease","volume":"19","author":"F Loeffelbein","year":"2014","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1111\/jth.14208","article-title":"Acquired von Willebrand syndrome in congenital heart disease surgery: results from an observational case-series","volume":"16","author":"V Icheva","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/heart.88.1.87","article-title":"Acquired von Willebrand syndrome in children with patent ductus arteriosus","volume":"88","author":"R Rauch","year":"2002","journal-title":"Heart"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5830\/CVJA-2015-093","article-title":"Acquired von Willebrand syndrome in children with aortic and pulmonary stenosis","volume":"27","author":"F K Binneto\u011flu","year":"2016","journal-title":"Cardiovasc J Afr"},{"issue":"06","key":"ref11","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ejcts\/ezy408","article-title":"Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support","volume":"55","author":"R Kubicki","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fcvm.2019.00137","article-title":"Platelet phenotype and function in the setting of pediatric extracorporeal membrane oxygenation (ECMO): a systematic review","volume":"6","author":"H P Yaw","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"08","key":"ref13","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.healun.2018.03.013","article-title":"Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: rapid onset and fast recovery","volume":"37","author":"J Kalbhenn","year":"2018","journal-title":"J Heart Lung Transplant"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V64.5.981.981","article-title":"Acquired von Willebrand's disease in the myeloproliferative syndrome","volume":"64","author":"U Budde","year":"1984","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"bcr04.2009.1816","DOI":"10.1136\/bcr.04.2009.1816","article-title":"Acquired von Willebrand syndrome in a 10-year-old girl with acute lymphoblastic leukaemia","volume":"2009","author":"I Dorn","year":"2009","journal-title":"BMJ Case Rep"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/bjh.16241","article-title":"Bleeding signs due to acquired von Willebrand syndrome at diagnosis of chronic myeloid leukaemia in children","volume":"188","author":"R Kn\u00f6fler","year":"2020","journal-title":"Br J Haematol"},{"issue":"03","key":"ref18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000206119","article-title":"Acquired type I von Willebrand's disease in a patient with essential thrombocytosis","volume":"75","author":"A Casonato","year":"1986","journal-title":"Acta Haematol"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/s-0039-1679929","article-title":"Fulminant essential thrombocythemia associated with acquired von Willebrand syndrome and bleeding episodes in a 14-year-old girl","volume":"39","author":"C Schneider","year":"2019","journal-title":"Hamostaseologie"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/107602960100700205","article-title":"Acquired von Willebrand syndrome in systemic lupus erythematodes","volume":"7","author":"J J Michiels","year":"2001","journal-title":"Clin Appl Thromb Hemost"},{"issue":"14","key":"ref21","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1177\/0961203313502862","article-title":"Rituximab effectiveness in a patient with juvenile systemic lupus erythematosus complicated with acquired Von Willebrand syndrome","volume":"22","author":"A RT Jimenez","year":"2013","journal-title":"Lupus"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1515\/jpem-2019-0082","article-title":"Acquired von Willebrand's syndrome caused by primary hypothyroidism in a 5-year-old girl","volume":"32","author":"C Flot","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"09","key":"ref23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1515\/jpem.2010.155","article-title":"Investigation of acquired von Willebrand Syndrome in children with hypothyroidism: reversal after treatment with thyroxine","volume":"23","author":"O Olukman","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/107602960100700204","article-title":"Atypical variant of acquired von Willebrand syndrome in Wilms tumor: is hyaluronic acid secreted by nephroblastoma cells the cause?","volume":"7","author":"J Michiels","year":"2001","journal-title":"Clin Appl Thromb Hemost"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ajh.2830240304","article-title":"Platelet dysfunction associated with Wilms tumor and hyaluronic acid","volume":"24","author":"A W Bracey","year":"1987","journal-title":"Am J Hematol"},{"issue":"06","key":"ref26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10545-005-0184-9","article-title":"Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia","volume":"28","author":"C M\u00fchlhausen","year":"2005","journal-title":"J Inherit Metab Dis"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/bjh.15530","article-title":"Idiopathic pulmonary arterial hypertension - a unrecognized cause of high-shear high-flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children","volume":"183","author":"M C Pelland-Marcotte","year":"2018","journal-title":"Br J Haematol"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-3476(05)82413-8","article-title":"Acquired von Willebrand disease after Epstein-Barr virus infection","volume":"119","author":"S Kinoshita","year":"1991","journal-title":"J Pediatr"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1528-1157.1992.tb02303.x","article-title":"Valproate therapy induces von Willebrand disease type I","volume":"33","author":"W Kreuz","year":"1992","journal-title":"Epilepsia"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1790-6156.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T03:08:04Z","timestamp":1651288084000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1790-6156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":28,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2022,4,29]]},"published-print":{"date-parts":[[2022,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1790-6156","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}